STOCK TITAN

Stitch Fix, Inc. (SFIX) CTO sells 70K shares after exercising 50K options

(Moderate)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Stitch Fix, Inc. Chief Product and Technology Officer Anthony Bacos exercised employee stock options for 50,000 shares of Class A Common Stock at an exercise price of $2.4800 per share and received 50,000 shares on July 20, 2026.

On the same date, he sold a total of 70,000 shares of Class A Common Stock in open-market transactions at weighted average prices of $3.7870 and $3.7865 per share, with actual sale prices ranging from $3.74–$3.84 per share. These transactions were made under a Rule 10b5-1 plan entered into on March 17, 2026. After the option exercise, he held 422,543 stock options from the same grant, which vest in stages through future quarterly vesting dates and expire on April 1, 2034.

Positive

  • None.

Negative

  • None.
Insider Bacos Anthony
Role Chief Prod/Technology Officer
Sold 70,000 shs ($265K)
Approx. gross sale proceeds $265K
Approx. exercise cost $124K
Type Security Shares Price Value
Exercise Employee Stock Option (Right to Buy) F1, F4 50,000 $0.00 $0.00
Exercise Class A Common Stock F1 50,000 $2.48 $124K
Sale Class A Common Stock F1, F2 50,000 $3.787 $189K
Sale Class A Common Stock F1, F3 20,000 $3.7865 $76K
Holdings After Transaction: Employee Stock Option (Right to Buy) — 422,543 shares (Direct); Class A Common Stock — 991,994 shares (Direct)
Footnotes (4)
  1. F1. This transaction was made pursuant to a Rule 10b5-1 plan entered into on March 17, 2026.
  2. F2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.74 to $3.84 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.735 to $3.84 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4. 25% of the shares subject to the Option vested on June 12, 2024. The remaining shares subject to the Option shall vest as follows: 25% of the shares in equal quarterly installments over the next two (2) quarterly vesting dates; 33 1/3% of the shares in equal quarterly installments over the next four (4) quarterly vesting dates; and 16 2/3% of the shares in equal quarterly installments over the next four (4) quarterly vesting dates, subject to the recipient's continuous service through each vesting date.
Options exercised 50,000 shares Employee Stock Option (Right to Buy) exercised on July 20, 2026
Option exercise price $2.4800 per share Exercise price for 50,000 Employee Stock Options
Shares sold (block 1) 50,000 shares Class A Common Stock sold at weighted average $3.7870 per share
Shares sold (block 2) 20,000 shares Class A Common Stock sold at weighted average $3.7865 per share
Total shares sold 70,000 shares Aggregate Class A Common Stock sales on July 20, 2026
Remaining options from grant 422,543 options Stock options held after exercising 50,000 from the grant
Option expiration date April 1, 2034 Expiration for the Employee Stock Option grant
10b5-1 plan adoption date March 17, 2026 Date the Rule 10b5-1 trading plan was entered into
Rule 10b5-1 plan regulatory
"This transaction was made pursuant to a Rule 10b5-1 plan entered into"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average sale price financial
"The reported price in Column 4 is a weighted average sale price."
Employee Stock Option (Right to Buy) financial
"security_title: Employee Stock Option (Right to Buy)"
Class A Common Stock financial
"underlying_security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
vesting dates financial
"equal quarterly installments over the next four (4) quarterly vesting dates"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did SFIX executive Anthony Bacos report in this Form 4?

Anthony Bacos reported exercising 50,000 stock options at $2.4800 and then selling 70,000 shares of Stitch Fix, Inc. (SFIX) Class A Common Stock in open-market transactions on July 20, 2026.

How many Stitch Fix (SFIX) shares did Anthony Bacos sell and at what prices?

He sold a total of 70,000 shares of SFIX Class A Common Stock at weighted average prices of $3.7870 and $3.7865 per share, with individual trade prices ranging between $3.74 and $3.84.

What options did the SFIX CTO exercise in this transaction?

The SFIX Chief Product and Technology Officer exercised 50,000 Employee Stock Options with an exercise price of $2.4800 per share, converting them into 50,000 shares of Class A Common Stock on July 20, 2026.

Were the SFIX insider transactions made under a Rule 10b5-1 plan?

Yes. The filing states the transactions were made pursuant to a Rule 10b5-1 plan that Anthony Bacos entered into on March 17, 2026, indicating a pre-arranged trading schedule.

How many Stitch Fix (SFIX) options does Anthony Bacos retain from this grant?

After exercising 50,000 options, Anthony Bacos held 422,543 stock options from the same grant. These options vest in specified quarterly installments and expire on April 1, 2034.

What is the vesting schedule of the SFIX options referenced in the Form 4?

According to a footnote, 25% of the option vested on June 12, 2024, with additional tranches vesting in equal quarterly installments over the next two, four, and four quarterly vesting dates, subject to continued service.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bacos Anthony

(Last)(First)(Middle)
1 MONTGOMERY STREET

(Street)
SAN FRANCISCO CALIFORNIA 94104

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Stitch Fix, Inc. [ SFIX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Prod/Technology Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock07/20/2026M(1)50,000A$2.481,061,994D
Class A Common Stock07/20/2026S(1)50,000D$3.787(2)1,011,994D
Class A Common Stock07/20/2026S(1)20,000D$3.7865(3)991,994D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy)$2.4807/20/2026M(1)50,000 (4)04/01/2034Class A Common Stock50,000$0422,543D
Explanation of Responses:
1. This transaction was made pursuant to a Rule 10b5-1 plan entered into on March 17, 2026.
2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.74 to $3.84 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.735 to $3.84 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. 25% of the shares subject to the Option vested on June 12, 2024. The remaining shares subject to the Option shall vest as follows: 25% of the shares in equal quarterly installments over the next two (2) quarterly vesting dates; 33 1/3% of the shares in equal quarterly installments over the next four (4) quarterly vesting dates; and 16 2/3% of the shares in equal quarterly installments over the next four (4) quarterly vesting dates, subject to the recipient's continuous service through each vesting date.
Remarks:
/s/ Casey O'Connor, Attorney-in-Fact for Anthony Bacos07/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)